Band 1
Band 2
About
Provided by Christophe Ronse
Practice Areas
Christophe is a partner in the IP & Litigation department of ALTIUS and leads the firm’s Life Sciences and Patents practice.
He is particularly specialised in intellectual property, with a focus on patent law, and healthcare law. He advises and assists national and international clients in complex litigation at the Belgian level and in national and international arbitration.
Professional Memberships
Member of INTA, LES, EPLAW
Former President of AIPPI’s Belgian association
Serves on the AIPPI Standing Committee on Pharma & Biotechnology.
Member of the editorial board of ICIP
Deputy judge at the Court of Appeal of Brussels
Active member of the International Bar Association (IBA), serves on the IBA Technology Law Committee.
Publications
Regular contributor of legal articles / speaker at conferences in the field of IP Law
Inaugural address to the Brussels Bar Association for the judicial year 2005-2006.
- “The Pharma Legal Handbook, Belgium”, Pharma Boardroom, December 2019 (with Kirian Claeyé)
- “Evoluties in het octrooirecht – Overzicht van rechtspraak 2014-2018”, TBH-RDC 2018, 747-798
- "Het lot van de licentievergoedingen in geval van herroeping of nietigverklaring van het octrooi : een problematiek met talrijke facetten", ICIP 2016, 1-22.
Chambers Review
Europe
The market-leading Christophe Ronse remains a go-to lawyer for well-known pharmaceutical companies in patent infringement and invalidity disputes. He also stands out for his ability to negotiate intellectual property licences.
Christophe Ronse advises clients on market access, procurement and disputes relating to medical products. He also has prominent experience assisting pharmaceutical clients with SPCs, parallel imports and IP litigation.
Articles, highlights and press releases
1 item provided by ALTIUS
Changes in the law on marketing of veterinary medicines: what you need to know
In this blog post, we provide an overview of the key changes related to the marketing of veterinary medicines set out in Chapters 4 and 14 of the new Law.
Changes in the law on marketing of veterinary medicines: what you need to know
In this blog post, we provide an overview of the key changes related to the marketing of veterinary medicines set out in Chapters 4 and 14 of the new Law.